Use of Integra dermal substitute to prevent implantable device extrusion in an Olympic athlete

BMJ Case Rep. 2018 Nov 8:2018:bcr2018226181. doi: 10.1136/bcr-2018-226181.

Abstract

We present a challenging case of imminent metallic implant extrusion in a Paralympic athlete managed with a single-stage procedure using 'Integra' dermal substitute. The patient had hereditary spastic paraparesis, for which a baclofen pump delivering intrathecal medication was vital in the management of his condition. The device had been most recently implanted into the thigh after previous complications. Integra provided robust soft-tissue coverage over the implanted baclofen pump in the thigh. Different operative management strategies were considered but the use of Integra was felt to offer the least morbidity and a quick recovery. The patient was able to successfully compete in a Paralympic canoeing qualifying event the week following surgery and achieve medal success. To the authors' knowledge, this is first case in which Integra has been used in such circumstances.

Keywords: plastic and reconstructive surgery; rehabilitation medicine; sports and exercise medicine; surgery.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Athletes*
  • Baclofen / administration & dosage
  • Chondroitin Sulfates / therapeutic use*
  • Collagen / therapeutic use*
  • Humans
  • Infusion Pumps, Implantable*
  • Male
  • Plastic Surgery Procedures / methods*
  • Treatment Outcome
  • Water Sports
  • Wound Healing*

Substances

  • integra artificial skin
  • Chondroitin Sulfates
  • Collagen
  • Baclofen